It has been hypothesized that development of CAAR-T cells, expressing citrullinated antigens, would allow selective deletion of B cells producing anti-citrullinated protein Abs (ACPA, a hallmark of RA), while saving other B cells (41). The gene discussed is PRTN3; the disease is rheumatoid arthritis.